Skip to main content
  • Saved

made a Post

Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors

Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors

Source :

https://doi.org/10.3389/fonc.2020.00570

Immunotherapy has revolutionized the treatment of both hematological malignancies and solid tumors. The use of immunotherapy has improved outcome for patients with cancer across multiple tumor types, including lung, melanoma, ovarian, genitourinary, and more recently breast cancer with durable responses seen even in patients with widespread metastatic disease.